CITATION: PD-L1/PD-1 Inhibitors and Beyond

A peer-reviewed article that appeared in the Journal of Pharmacology and Clinical Research by David....
Read More

Strategic Metrics Dedicated to Medical Affairs

Metrics that bridge the gap to Medical Affairs 2.0 Historically, decisions for the generation and....
Read More

PRESS: Harnessing the Unrivaled Power of Key Opinion Leaders

This month's Pharmaceutical Market Europe Magazine features a thought leadership article from Medmeme.  The article discusses the....
Read More

TRANSFORMING DATA INTO
ACTIONABLE KNOWLEDGE

Researching, developing and launching new drugs is a massive, all-in investment. In order to appropriately set direction, equip teams, and create and execute effective go-to-market strategies on new drug formulations, having volumes of data isn’t the answer — having the right information is.